Patent details

EP3054961 Title: ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS

Basic Information

Publication number:
EP3054961
PCT Application Number:
IL2014050887
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148515471
PCT Publication Number:
WO2015052716
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS
French Title of Invention:
ACTIVATION DE PROGÉNITEURS HÉMATOPOIÉTIQUES PAR EXPOSITION AVANT LA GREFFE AUX LIGANDS DE MORT
German Title of Invention:
AKTIVIERUNG VON HÄMATOPOIETISCHEN VORLÄUFERN DURCH PRÄTRANSPLANT-AUSSETZUNG GEGEN TODESLIGANDEN
SPC Number:

Dates

Filing date:
07/10/2014
Grant date:
26/08/2020
EP Publication Date:
17/08/2016
PCT Publication Date:
16/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/08/2020
EP B1 Publication Date:
26/08/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/10/2020
Expiration date:
07/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/08/2020
 
 

Name:
Cellect Biotherapeutics Ltd.
Address:
23 Hata'as Street 3rd Floor, Kfar Saba 4442510, Israel (IL)

Inventor

Name:
YARKONI, Shai
Address:
Israel (IL)

Priority

Priority Number:
201361888713 P
Priority Date:
09/10/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/19; A61P 37/00; A61K 35/28; A61K 35/51;

Publication

European Patent Bulletin

Issue number:
202035
Publication date:
26/08/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages